Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oglemilast Dose-Ranging Study in COPD
NCT00671073Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- May 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oglemilast in chronic obstructive pulmonary disease (COPD), sponsored by Forest Laboratories. Started May 2008; status: completed.
02
Drugs
oglemilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00671073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671073.